However, although deregulated protein aggregation is recognized as a common feature of neurodegenerative diseases, little is known about how a-synuclein aggregates contribute to neurodegeneration and the development of motor and non-motor symptoms in PD. This evidence concerns the gene SNCA and Parkinson disease.